标题
Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers
作者
关键词
IDH1, ATRX, BRAF, Molecular classification, Next-generation sequencing, Astrocytoma
出版物
ACTA NEUROPATHOLOGICA
Volume 129, Issue 6, Pages 789-808
出版商
Springer Nature
发表日期
2015-05-14
DOI
10.1007/s00401-015-1439-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas
- (2015) Adriana Olar et al. ACTA NEUROPATHOLOGICA
- BRAFMutation andCDKN2ADeletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma
- (2015) Matthew Mistry et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutational landscape and clonal architecture in grade II and III gliomas
- (2015) Hiromichi Suzuki et al. NATURE GENETICS
- Cell of Origin for Malignant Gliomas and Its Implication in Therapeutic Development
- (2015) Hui Zong et al. Cold Spring Harbor Perspectives in Biology
- CONTENTS
- (2015) NEUROLOGIA MEDICO-CHIRURGICA
- Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
- (2015) Yuchen Jiao et al. Oncotarget
- Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
- (2015) Kasthuri Kannan et al. Oncotarget
- The genetic landscape of anaplastic astrocytoma
- (2015) Patrick J. Killela et al. Oncotarget
- Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas
- (2015) Patrick J. Killela et al. Oncotarget
- Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma
- (2014) Benedikt Wiestler et al. ACTA NEUROPATHOLOGICA
- Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma
- (2014) Felix Sahm et al. ACTA NEUROPATHOLOGICA
- Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors
- (2014) Joshua Mangerel et al. ACTA NEUROPATHOLOGICA
- ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
- (2014) David E. Reuss et al. ACTA NEUROPATHOLOGICA
- Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications
- (2014) Pawel Buczkowicz et al. ACTA NEUROPATHOLOGICA
- A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas
- (2014) Sriram Venneti et al. ACTA NEUROPATHOLOGICA
- Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas
- (2014) Denise Bechet et al. ACTA NEUROPATHOLOGICA
- Genetic dissection of leukemia-associated IDH1 and IDH2 mutants and D-2-hydroxyglutarate in Drosophila
- (2014) Z. J. Reitman et al. BLOOD
- Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAFmutations
- (2014) Michaela Angelika Ihle et al. BMC CANCER
- International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading
- (2014) David N. Louis et al. BRAIN PATHOLOGY
- Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas
- (2014) Yukinari Kato Brain Tumor Pathology
- Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomas
- (2014) Hideyuki Arita et al. Brain Tumor Pathology
- Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH-Mutant Gliomas
- (2014) H. Wakimoto et al. CLINICAL CANCER RESEARCH
- Successive distinct high-grade gliomas in L-2-hydroxyglutaric aciduria
- (2014) Zoltan Patay et al. JOURNAL OF INHERITED METABOLIC DISEASE
- The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma
- (2014) Sani H. Kizilbash et al. JOURNAL OF NEURO-ONCOLOGY
- Oncogenic Signaling Is Dominant to Cell of Origin and Dictates Astrocytic or Oligodendroglial Tumor Development from Oligodendrocyte Precursor Cells
- (2014) N. Lindberg et al. JOURNAL OF NEUROSCIENCE
- EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
- (2014) Michael Weller et al. LANCET ONCOLOGY
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas
- (2014) N. Sabha et al. NEURO-ONCOLOGY
- Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial
- (2014) B. Wiestler et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma
- (2014) Xiaowei Guan et al. PLoS One
- Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation
- (2014) Fumiharu Ohka et al. TUMOR BIOLOGY
- ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis
- (2013) Benedikt Wiestler et al. ACTA NEUROPATHOLOGICA
- What do we know about IDH1/2 mutations so far, and how do we use it?
- (2013) Craig Horbinski ACTA NEUROPATHOLOGICA
- Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors
- (2013) Pilar Mur et al. ACTA NEUROPATHOLOGICA
- Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
- (2013) Hideyuki Arita et al. ACTA NEUROPATHOLOGICA
- Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system
- (2013) Christian Koelsche et al. ACTA NEUROPATHOLOGICA
- TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
- (2013) Marc Remke et al. ACTA NEUROPATHOLOGICA
- Evaluation of Histone 3 Lysine 27 Trimethylation (H3K27me3) and Enhancer of Zest 2 (EZH2) in Pediatric Glial and Glioneuronal Tumors Shows Decreased H3K27me3 inH3F3AK27M Mutant Glioblastomas
- (2013) Sriram Venneti et al. BRAIN PATHOLOGY
- Cigarette smoking, alcohol intake and risk of glioma in the NIH-AARP Diet and Health Study
- (2013) M Z Braganza et al. BRITISH JOURNAL OF CANCER
- The CpG Island Methylator Phenotype: What's in a Name?
- (2013) L. A. E. Hughes et al. CANCER RESEARCH
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas
- (2013) Caitlin Ann Routhier et al. HUMAN PATHOLOGY
- Outcomes for patients with anaplastic astrocytoma treated with chemoradiation, radiation therapy alone or radiation therapy followed by chemotherapy: a retrospective review within the era of temozolomide
- (2013) Nicole A. Shonka et al. JOURNAL OF NEURO-ONCOLOGY
- Interlaboratory comparison of IDH mutation detection
- (2013) Martin J. van den Bent et al. JOURNAL OF NEURO-ONCOLOGY
- Expanding the spectrum of IDH1 mutations in gliomas
- (2013) Ruta Gupta et al. MODERN PATHOLOGY
- The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas
- (2013) Malak Abedalthagafi et al. MODERN PATHOLOGY
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
- (2013) NATURE GENETICS
- Current Knowledge and Treatment Strategies for Grade II Gliomas
- (2013) Yoshitaka NARITA NEUROLOGIA MEDICO-CHIRURGICA
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1
- (2013) L. A. Ramkissoon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
- (2013) P. W. Lewis et al. SCIENCE
- Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
- (2013) B. E. Johnson et al. SCIENCE
- An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
- (2013) D. Rohle et al. SCIENCE
- Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
- (2013) F. Wang et al. SCIENCE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Alternative lengthening of telomeres: remodeling the telomere architecture
- (2013) Dimitri Conomos et al. Frontiers in Oncology
- Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
- (2012) Xiao-Yang Liu et al. ACTA NEUROPATHOLOGICA
- K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
- (2012) Dong-Anh Khuong-Quang et al. ACTA NEUROPATHOLOGICA
- Comparison of a Strategy Favoring Early Surgical Resection vs a Strategy Favoring Watchful Waiting in Low-Grade Gliomas
- (2012) Asgeir S. Jakola et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
- (2012) Nai-Kong V. Cheung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802
- (2012) Edward G. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
- (2012) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas
- (2012) Rezvan Ahmadi et al. JOURNAL OF NEURO-ONCOLOGY
- Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
- (2012) Wolfgang Wick et al. LANCET ONCOLOGY
- IDH mutation impairs histone demethylation and results in a block to cell differentiation
- (2012) Chao Lu et al. NATURE
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
- (2012) Sevin Turcan et al. NATURE
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
- (2012) Jeremy Schwartzentruber et al. NATURE
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
- (2012) Gang Wu et al. NATURE GENETICS
- Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology)
- (2012) S. Scoccianti et al. NEURO-ONCOLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
- (2012) Courtney A. Lovejoy et al. PLoS Genetics
- Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing
- (2011) Shingo Takano et al. Brain Tumor Pathology
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients
- (2011) Akitake Mukasa et al. CANCER SCIENCE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic?
- (2011) C. Hartmann et al. CLINICAL CANCER RESEARCH
- A 4-Gene Signature Associated with Clinical Outcome in High-Grade Gliomas
- (2011) M. de Tayrac et al. CLINICAL CANCER RESEARCH
- Low-grade gliomas in adults
- (2011) Nader Sanai et al. JOURNAL OF NEUROSURGERY
- Natural history and surgical management of incidentally discovered low-grade gliomas
- (2011) Matthew B. Potts et al. JOURNAL OF NEUROSURGERY
- An in vivo patient-derived model of endogenous IDH1-mutant glioma
- (2011) H. A. Luchman et al. NEURO-ONCOLOGY
- Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
- (2011) Z. J. Reitman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Altered Telomeres in Tumors with ATRX and DAXX Mutations
- (2011) C. M. Heaphy et al. SCIENCE
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing
- (2010) Jörg Felsberg et al. ACTA NEUROPATHOLOGICA
- The prognostic IDH1 R132 mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma
- (2010) Fonnet E. Bleeker et al. ACTA NEUROPATHOLOGICA
- Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
- (2010) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- Molecular diagnostics of gliomas: state of the art
- (2010) Markus J. Riemenschneider et al. ACTA NEUROPATHOLOGICA
- Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
- (2010) Philippe Metellus et al. ACTA NEUROPATHOLOGICA
- Molecular Classification of Low-Grade Diffuse Gliomas
- (2010) Young-Ho Kim et al. AMERICAN JOURNAL OF PATHOLOGY
- Application of Mutant IDH1 Antibody to Differentiate Diffuse Glioma From Nonneoplastic Central Nervous System Lesions and Therapy-induced Changes
- (2010) David Capper et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Natural history of incidental world health organization grade II gliomas
- (2010) Johan Pallud et al. ANNALS OF NEUROLOGY
- Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium
- (2010) Melissa L. Bondy et al. CANCER
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1
- (2010) M. J. Seltzer et al. CANCER RESEARCH
- IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children’s Oncology Group
- (2010) Ian F. Pollack et al. CHILDS NERVOUS SYSTEM
- Guidelines on management of low-grade gliomas: report of an EFNS-EANO* Task Force
- (2010) R. Soffietti et al. EUROPEAN JOURNAL OF NEUROLOGY
- ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells
- (2010) L. H. Wong et al. GENOME RESEARCH
- COLD PCR HRM: a highly sensitive detection method for IDH1 mutations
- (2010) Blandine Boisselier et al. HUMAN MUTATION
- Post-contrast enhancement as a clinical indicator of prognosis in patients with anaplastic astrocytoma
- (2010) Elie Matar et al. JOURNAL OF CLINICAL NEUROSCIENCE
- IDH1andIDH2Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- (2010) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of IDH1 and IDH2 Mutations by Fluorescence Melting Curve Analysis as a Diagnostic Tool for Brain Biopsies
- (2010) Craig Horbinski et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis
- (2010) K. A. Jaeckle et al. JOURNAL OF NEURO-ONCOLOGY
- Isocitrate Dehydrogenase 1 and 2 Mutations in Cancer: Alterations at a Crossroads of Cellular Metabolism
- (2010) Z. J. Reitman et al. JNCI-Journal of the National Cancer Institute
- IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
- (2010) C. Houillier et al. NEUROLOGY
- Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres
- (2010) P. W. Lewis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IDH2 Mutations in Patients with D-2-Hydroxyglutaric Aciduria
- (2010) M. Kranendijk et al. SCIENCE
- Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndrome
- (2009) Takuya Watanabe et al. ACTA NEUROPATHOLOGICA
- Monoclonal antibody specific for IDH1 R132H mutation
- (2009) David Capper et al. ACTA NEUROPATHOLOGICA
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
- (2009) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
- (2009) Takuya Watanabe et al. AMERICAN JOURNAL OF PATHOLOGY
- A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation
- (2009) Yukinari Kato et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Analysis ofIDH1andIDH2mutations in Japanese glioma patients
- (2009) Yukihiko Sonoda et al. CANCER SCIENCE
- Adult Supratentorial Low-Grade Glioma: Long-Term Experience at a Single Institution
- (2009) Glenn Bauman et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Pediatric Low-Grade Gliomas
- (2009) Angela J. Sievert et al. JOURNAL OF CHILD NEUROLOGY
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
- (2009) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas
- (2009) Kaisorn L. Chaichana et al. JOURNAL OF NEUROSURGERY
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas
- (2009) Koichi Ichimura et al. NEURO-ONCOLOGY
- IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide
- (2009) H. J. Dubbink et al. NEUROLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1
- (2009) S. Zhao et al. SCIENCE
- The interface between glial progenitors and gliomas
- (2008) Peter Canoll et al. ACTA NEUROPATHOLOGICA
- Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas
- (2008) Justin S. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review
- (2008) Mahdi Aghili et al. JOURNAL OF NEURO-ONCOLOGY
- Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial
- (2008) Edward G. Shaw et al. JOURNAL OF NEUROSURGERY
- Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data
- (2008) L. P. Petalidis et al. MOLECULAR CANCER THERAPEUTICS
- Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic
- (2008) David A. Schomas et al. NEURO-ONCOLOGY
- Prognostic significance of imaging contrast enhancement for WHO grade II gliomas
- (2008) Johan Pallud et al. NEURO-ONCOLOGY
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now